FDA Inspection
Haupt Pharma Amareg GmbHHaupt Pharma Amareg GmbH – FDA Inspection, Jul 26, 2024
Record Details
This FDA Inspection record concerns Haupt Pharma Amareg GmbH, with an inspection on July 26, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Haupt Pharma Amareg GmbH
- Inspection Date
- July 26, 2024
- Product Type
- Drugs
View Company Profile
ID · c2c3b316-3961-4c7b-9293-5fcc6a5dc890
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1274881
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Haupt Pharma Amareg GmbH
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 10, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 22, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2011 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Haupt Pharma Amareg GmbH
- FDA Inspection 1134674 - 2019-06-07
- FDA Inspection 1038904 - 2017-11-10
- FDA Inspection 986248 - 2016-08-26
- FDA Inspection 857318 - 2013-11-22
- FDA Inspection 727709 - 2011-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.